Development of an Improved Lentiviral Based Vector System for the Stable Expression of Monoclonal Antibody in Cho Cells Publisher Pubmed



Mohammadian O¹ ; Rajabibazl M^{1, 2} ; Pourmaleki E^{2, 3} ; Bayat H^{2, 4} ; Ahani R² ; Rahimpour A^{2, 3}
Source: Preparative Biochemistry and Biotechnology Published:2019

Abstract

Therapeutic monoclonal antibodies (mAbs) have become the dominant products in biopharmaceutical industry. Mammalian cell expression systems including Chinese hamster ovary (CHO) cells are the most commonly used hosts for the production of complex recombinant proteins. However, development of stable, high producing CHO cell lines suffers from the low expression level and instability of the transgene. The increasing efforts in the development of novel therapeutic antibodies and the advent of biosimilars have revealed the necessity for the development of improved platforms for rapid production of products for initial characterization and testing. In line with this premise, vector design and engineering has been applied to improve the expression level and stability of the transgene. This study reports the application of an improved lentiviral vector system containing the human interferon-β scaffold attachment region (IFN-SAR) for the development of antibody producing stable CHO cells. mAb expressing clones producing 1100 µg/L of IgG1 monoclonal antibody were isolated without extensive screening of a large number of clones. Our results here indicate the positive effects of IFN-SAR on stable mAb expression using lentiviral based expression vectors. We also observed that although IFN-SAR can improve light chain (LC) and heavy chain (HC) gene copy numbers in stable cell pools, mAb expression in single cell clones was not affected by the transgene copy number. © 2019, © 2019 Taylor & Francis Group, LLC.